MiMedx Group, Inc.
MDXG
$7.08
-$0.23-3.15%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 98.61M | 88.21M | 92.91M | 84.06M | 87.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 98.61M | 88.21M | 92.91M | 84.06M | 87.21M |
| Cost of Revenue | 18.68M | 16.56M | 16.91M | 15.32M | 14.86M |
| Gross Profit | 79.92M | 71.65M | 76.00M | 68.74M | 72.35M |
| SG&A Expenses | 64.15M | 59.97M | 61.09M | 54.17M | 45.70M |
| Depreciation & Amortization | 100.00K | 99.00K | 193.00K | 192.00K | 190.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 86.24M | 79.95M | 81.76M | 72.60M | 63.76M |
| Operating Income | 12.37M | 8.25M | 11.15M | 11.46M | 23.45M |
| Income Before Tax | 13.01M | 8.61M | 11.25M | 11.42M | 23.22M |
| Income Tax Expenses | 3.39M | 1.59M | 3.81M | 3.54M | 5.60M |
| Earnings from Continuing Operations | 9.62M | 7.02M | 7.44M | 7.88M | 17.62M |
| Earnings from Discontinued Operations | -- | -- | 0.00 | 217.00K | 4.00K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.62M | 7.02M | 7.44M | 8.10M | 17.63M |
| EBIT | 12.37M | 8.25M | 11.15M | 11.46M | 23.45M |
| EBITDA | 15.51M | 11.48M | 14.14M | 12.62M | 24.58M |
| EPS Basic | 0.07 | 0.05 | 0.05 | 0.06 | 0.12 |
| Normalized Basic EPS | 0.06 | 0.04 | 0.05 | 0.05 | 0.10 |
| EPS Diluted | 0.06 | 0.05 | 0.05 | 0.05 | 0.12 |
| Normalized Diluted EPS | 0.05 | 0.04 | 0.05 | 0.05 | 0.10 |
| Average Basic Shares Outstanding | 147.76M | 147.27M | 147.01M | 146.96M | 147.33M |
| Average Diluted Shares Outstanding | 149.32M | 149.68M | 149.24M | 148.37M | 148.90M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | 2.42% | -- | -- | -- |